Mustafa Cem Algin

Prof. Dr. Mustafa Cem Algin

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
AZAkile Zengin
Akile Zengin
AEAçelya Erikçi
Açelya Erikçi
GTGokcen Telli
Gokcen Telli
BGBülent Gümüşel
Bülent Gümüşel
KKKemal Kösemehmetoğlu
Kemal Kösemehmetoğlu
MAMustafa Cem Algin
Mustafa Cem Algin
Objective: Hepatic ischemia-reperfusion (IR) injury occurs in liver surgery, resection, and transplantation. Reactive oxygen species (ROS) produced following IR starts the cascade of cell damage, necrosis/apoptosis, and proinflammatory responses by activating intracellular signaling cascade to drive hepatocellular damage. Cerium oxide nanoparticles (CONPs) act as anti-inflammatory and antioxidant agents. Thus, we evaluated the protective effects of oral (o.g.) and intraperitoneal (i.p.) administration of CONPs on hepatic IR injury. Material and Methods: Mice were randomly divided into five groups: control, sham, IR protocol, CONP+IR (i.p.), and CONP+IR (o.g.). Mouse hepatic IR protocol was applied to the animals in the IR group. CONPs (300 μg/kg) were administered 24 hours before IR protocol. Blood and tissue samples were taken after the reperfusion period. Results: Hepatic IR injury markedly increased enzyme activities, tissue lipid peroxidation, myeloperoxidase (MPO), xanthine oxidase (XO), nitrite oxide (NO), and tissue nuclear factor kappa-B (NF-κB) p65 levels, plasma pro-inflammatory cytokines, chemokines, and adhesion molecules while decreasing antioxidant markers and caused pathological changes in hepatic tissue. The expression of tumor necrosis factor alpha (TNF-α), matrix metalloproteinase 2 (MMP-2), and 9 increased, and tissue inhibitor matrix metalloproteinase 1 (TIMP-1) expression decreased in the IR group. Pretreatment with CONPs o.g. and i.p. 24 hours before hepatic ischemia improved the biochemical parameters above and alleviated the histopathological findings. Conclusion: Results of the present study demonstrate a significant reduction in liver degeneration by administering CONPs via i.p. and o.g. route in an experimental liver IR model, suggesting that CONPs have the extensive potential to prevent hepatic IR injury.

10 June 2020 in Turkish Journal of Colorectal Disease
Verified
Journal Article
Closed access
HAHüseyin Emre Arslan
Hüseyin Emre Arslan
SZSezgin Zeren
Sezgin Zeren
MEMehmet Fatih Ekici
Mehmet Fatih Ekici
MAMustafa Cem Algin
Mustafa Cem Algin

24 November 2015 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
FYF. Yaylak
F. Yaylak
ADA. Deger
A. Deger
ZBZ. Bayhan
Z. Bayhan
CKC. Kocak
C. Kocak
SZS. Zeren
S. Zeren
MAMustafa Cem Algin
Mustafa Cem Algin

1 January 2025 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
HAHuseyin Emre Arslan
Huseyin Emre Arslan
YTYasemin Teksen
Yasemin Teksen
OÖOrhan Özatik
Orhan Özatik
MAMustafa Cem Algin
Mustafa Cem Algin
Purpose: To investigate the potential pleiotropic effects of liraglutide (LG), a glucagon-like-peptide-1 analog, on gastric ulcer prevention in rats with diabetes induced by streptozotocin (STZ). Methods: We randomly divided 63 male Wistar rats into seven groups. STZ was administered intraperitoneally (IP) to the animals in the diabetic control (group STZ), diabetic control + indomethacin (INDO) (group STZI), STZ + INDO + omeprazole (group OMP), STZ + INDO + LG (0.2 mg/kg) (group 0.2LG), and STZ + INDO + LG (0.4 mg/kg) group (group 0.4LG). We administered OMP IP to group OMP, 0.2 mg/kg LG to group 0.2LG SC, 0.4 mg/kg LG to group 0.4LG SC, normal saline to non-diabetic control (sham group), group STZ, non-diabetic control + INDO (group KI), and group STZI SC. INDO was administered to the animals in groups KI, STZI, OMP, 0.2LG, and 0.4LG by gavage. Then, the caspase-3, epidermal growth factor (EGF), vascular endothelial growth factor-A (VEGF-A), prostaglandin E2 (PGE2), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), superoxide dismutase-1 (SOD-1), glutathione (GSH), and malondialdehyde (MDA) levels were studied. Results: LG prevented INDO-induced ulcers and decreased apoptosis in the stomach tissue. It increased the SOD-1, GSH, EGF, VEGF-A, and PGE2 levels, and reduced the MDA, IL-6, and TNF-α levels. The anti-ulcer effect of LG was lower, but close to that of OMP. Conclusion: The antioxidant, anti-inflammatory, and anti-apoptotic effects of LG, its ability to regulate EGF, VEGF-A, and PGE2 levels, and its capacity to reduce blood glucose levels in diabetic rats may contribute to its anti-ulcer effect.

30 May 2022 in Marmara Medical Journal
Verified
Journal Article
Closed access
PDF file
AYAli Cihat Yildirim
Ali Cihat Yildirim
SASevil Alkan
Sevil Alkan
SZSezgin Zeren
Sezgin Zeren
MEMehmet Fatih Ekici
Mehmet Fatih Ekici
FYFaik Yaylak
Faik Yaylak
ÖAÖzlem Arik
Özlem Arik
Objective: COVID-19 pandemic has infected the entire world and causes obsolete morbidity and mortality. While respiratory symptoms are the most frequently reported, several recent studies revealed that gastrointestinal symptoms are not uncommon. Our aim in this observational study is to reveal the gastrointestinal symptoms of COVID-19 patients. Patients and Methods: Data of COVID-19 patients with gastrointestinal symptoms were recorded and retrospectively analyzed during their hospital follow-up period. 82 patients participated in the study and later on had a positive polymerase chain reaction (PCR) test. Gender, age, systemic and gastrointestinal complaints, medical and surgical disease history, laboratory results, thorax computer tomography (CT) findings, and characteristics of gastrointestinal system (GIS) symptoms of patients were also recorded. Data were analyzed by statistical software. Results: The most common typical symptoms of COVID-19 patients were cough, anosmia, debility, and shortness of breath. Further, most of the gastrointestinal symptoms found in COVID-19 patients were nonspecific abdominal pain. Lymphopenia and elevated liver transaminases were the most common findings of the tests. Patients with diarrhea indicated watery diarrhea. Two patients also had ileus, they healed spontaneously without surgical intervention. Furthermore, all patients were discharged without any problems. Conclusion: Gastrointestinal symptoms are typical in COVID-19 patients. However, these symptoms do not seem to have a detrimental effect on the progression of the disease. In our study group, there was no need for surgical intervention, but COVID-19 patients with gastrointestinal symptoms should be treated by a multidisciplinary approach.

7 May 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
MAMustafa Cem Algin
Mustafa Cem Algin
MKMurat Özgür Kılıç
Murat Özgür Kılıç
MSMustafa Salış
Mustafa Salış
OAOzlem Arik
Ozlem Arik
OKOrhan Kalayci
Orhan Kalayci
UBUlku Busra Bayram
Ulku Busra Bayram
Background: The most frequently diagnosed malignancy among women worldwide is breast cancer. Inflammation, nutritional status, and immune competence are increasingly recognized as major determinants of tumor progression and prognosis in cancer cases. The C-reactive protein–albumin–lymphocyte (CALLY) index, a composite biomarker reflecting these parameters, has shown promise in studies of various tumors. However, research on the CALLY index in breast cancer remains limited in the literature. Objective: In this study, we evaluated the diagnostic significance and staging performance of the CALLY index in patients with breast carcinoma. Method: A total of 303 female patients diagnosed with breast cancer between November 2018 and December 2024 were retrospectively analyzed. Pre-treatment serum CRP, albumin, and lymphocyte counts were used to calculate the CALLY index (Albumin [g/dL] × Lymphocyte count [/µL])/(CRP [mg/dL] × 10 4) . Patients were classified into early-stage (Stage I-II) and advanced-stage (Stage III-IV) groups. Group comparisons were performed using Mann-Whitney U and Kruskal-Wallis tests. ROC analysis and supervised machine learning algorithms were used to evaluate the discriminative performance of the CALLY index and CA-15-3. Results: The mean CALLY index was significantly higher in early-stage patients compared to those with advanced-stage disease (p < 0.001). The index demonstrated excellent discriminative ability for staging, with an optimal cut-off value of 0.693 (AUC: 1.00; sensitivity: 100%; specificity: 100%). In multivariate analysis, the CALLY index outperformed CA 15–3 in predicting tumor stage. Machine learning classification confirmed that the CALLY index was the most important variable for stage prediction, and the neural network model achieved an accuracy of 84.9% on the test set. Conclusion: The CALLY index is one of the non-invasive and easily accessible biomarkers that can distinguish between early and advanced breast cancer by integrating inflammatory, nutrition and immune parameters. Furthermore, the CALLY index holds significant potential for pre-treatment prognostic stratification of breast cancer in clinical practice.